Orthobiologics are a group of treatment options that use substances naturally found in the body in an intensified concentration. Royal Biologics, an orthobiologics company specializing in the research and advancement of regenerative cellular therapy and novel orthobiologic solutions, announced the launch of MAGNUS, a dimethyl sulfoxide (DMSO)-free viable cellular bone allograft, for fusion in orthopedics. Magnus provides the 3 key elements ideal for bone formation: an osteoconductive 3D scaffold with cortical and cancellous components; a demineralized bone scaffold with osteoinductive potential; and viable spine-derived cells, preserved with the use of a DMSO-free cryoprotectant, to support osteogenic healing processes.
Royal Biologics
201/488-1549
